Pliant Partners with Cleveland Clinic to Find New Disease Targets for Gut Fibrosis

Pliant Partners with Cleveland Clinic to Find New Disease Targets for Gut Fibrosis
Pliant Therapeutics is starting a multi-year research collaboration with Cleveland Clinic to speed the discovery of new druggable targets for gastrointestinal fibrosis, a common gut complication in patients with inflammatory bowel disease (IBD). Fibrotic strictures in the bowel, a narrowing in the intestine which can make it difficult for food material to pass through, are often a consequence of IBD. As much as 40% of patients with ileal Crohn's disease (affecting the last part of the small intestine) will eventually have this condi
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *